15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes —2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidis ciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full l...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
6. Glycemic Targets: Standards of Care in Diabetes —2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidis ciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full l...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
Introduction and Methodology: Standards of Care in Diabetes —2023
Diabetes is a complex, chronic condition requiring continuous medical care with multifactorial risk-reduction strategies beyond glucose management. Ongoing diabetes self-management education and support are critical to empowering people, preventing acute complications, and reducing the risk of long-term complications. Significant evidence exists that supports a range of interventions to improve diabetes outcomes. (Source: Diabetes Care)
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes —2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidis ciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full l...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes —2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidis ciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full l...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes —2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidis ciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full l...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes —2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidis ciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full l...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
Index
A1C, S5, S8, S11, S12, S20,S21 –S22, S97 –S99advantages of, S21age and, S21 –S22cardiovascular disease and, S102 –S103CGM technology effect on, S106, S112, S115 –S116confirming diagnosis with, S22correlation with BGM, S98hemoglobinopathies and,S22in children, S98 –S99, S235–S237, S241–S242in hospitalized patients, S268in older adults, S219, S220, S223in people with HIV,S28in screening children,S28limitations,S98microvascular complications and, S101 –S102other conditions affecting,S22point-of-care assays, S5, S21, S98in prediabetes, S24 –S25in pregnancy, S256,S257 –S258race/ethnicity and,S22, S98 –S9...
Source: Diabetes Care - December 12, 2022 Category: Endocrinology Source Type: research
Questionnaire-Based Polyexposure Assessment Outperforms Polygenic Scores for Classification of Type 2 Diabetes in a Multiancestry Cohort
CONCLUSIONSOur findings in a multiancestry cohort elucidate how type 2 diabetes odds can be attributed to clinical, genetic, and environmental factors and emphasize the need for exposome data in disease-risk association studies. Race-based differences in predictive scores highlight the need for genetic and exposome-wide studies in diverse populations. (Source: Diabetes Care)
Source: Diabetes Care - November 16, 2022 Category: Endocrinology Source Type: research
Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study
CONCLUSIONSChanges in lipid and fatty acid content were significantly associated with CVD risk in the Chinese population with diabetes. PSM is a potential biomarker of increased CVD risk in diabetes. (Source: Diabetes Care)
Source: Diabetes Care - March 4, 2022 Category: Endocrinology Source Type: research
Prolonged Glycemic Adaptation Following Transition From a Low- to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial
CONCLUSIONSPhysiological adaptation from a low- to high-carbohydrate diet may require many weeks, with implications for the accuracy of diabetes tests, interpretation of macronutrient trials, and risks of periodic planned deviations from a VLC diet. (Source: Diabetes Care)
Source: Diabetes Care - March 4, 2022 Category: Endocrinology Source Type: research
Maternal Glycemic Dysregulation During Pregnancy and Neonatal Blood DNA Methylation: Meta-analyses of Epigenome-Wide Association Studies
CONCLUSIONSMaternal hyperglycemia, as reflected by AUCgluc, was associated with lower cord blood DNAm atTXNIP. Associations between DNAm at these CpGs and metabolic traits in subsequent lookup analyses suggest that these may be candidate loci to investigate in future causal and mediation analyses. (Source: Diabetes Care)
Source: Diabetes Care - March 4, 2022 Category: Endocrinology Source Type: research
Philip Home —Insulin, Insight, and Internationalism
Few people have influenced the fields of insulin pharmacokinetics and international diabetes guidelines more than Philip Home. His long career has been distinguished by involvement in many aspects of diabetes and a major international presence. (Source: Diabetes Care)
Source: Diabetes Care - March 4, 2022 Category: Endocrinology Source Type: research
Response to Comment on Sj öholm et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study. Diabetes Care 2022;45:444–450
We appreciate the comments by Rigalleau et al. (1) regarding our article (2) and agree that tissular accumulation of advanced glycation end products (AGEs) as an alternative mechanism that may contribute to the reduced incidence of cancer after the remission of diabetes is interesting. (Source: Diabetes Care)
Source: Diabetes Care - March 4, 2022 Category: Endocrinology Source Type: research
Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518 –2526
We appreciate the comments made by Rigalleau et al. (1) and their interest in our article (2), which quantified the incidence of proliferative diabetic retinopathy (PDR) and other neovascular complications within the first 5 years following an index diagnosis of type 2 diabetes. Further, we identified risk factors for developing PDR within 5 years of being diagnosed with type 2 diabetes, including hemoglobin A1c (HbA1c), renal disease, peripheral circulatory disorders, neurological disease, and older age. As has been previously reported, the diagnosis of type 2 diabetes may be delayed relative to its onset. (Source: Diabetes Care)
Source: Diabetes Care - March 4, 2022 Category: Endocrinology Source Type: research
